Top Stories
North Korea fires short-range missiles: South
North Korea has launched three guided missiles apparently as part of a military drill.
- New case of virus in Saudi Arabia
- Carbon tax may force new poll: coalition
- France legalises same-sex marriage
- Call for conscience vote on gay marriage
- Suspected asylum seeker boat in distress
- NASA records giant explosion on moon
- Strong 6.1 earthquake strikes off Japan
- Double dissolution threat a bluff: Greens
- Why are we debating 'blackface' in 2013?
-
-
SBS 10:30 News - 17 May part 1
17 May 13 | 9:00
-
-
SBS 10:30 News - 17 May part 2
17 May 13 | 6:00
-
-
SBS 10:30 News - 17 May part 3
17 May 13 | 4:00
-
-
Gina Rinehart warns of Euro-style collapse
17 May 13 | 2:14
-
-
US, Turkey mull plan to end Syrian crisis
17 May 13 | 1:00
-
-
Accolades flow for retiring Beckham
17 May 13 | 1:00
-
-
Advocates warn on mainland excision bill
17 May 13 | 1:00
-
-
Melbourne truck crash causes delays
17 May 13 | 1:00
-
-
Sydney shooting rates in decline: Police
17 May 13 | 2:00
-
-
Eurovision: Glitz, glam and politics
17 May 13 | 2:00
-
-
Cricket mired by spot-fixing scandal
17 May 13 | 1:00
-
-
Insight: Arranged Marriage preview
17 May 13 | 0:00
-
-
Hindi News Second Edition 18 May
18 May 13 | 14:00
-
-
Living Black: S18 Ep11 - Bourke Crime preview
16 May 13 | 1:00
-
-
Living Black: S18 Ep11 preview
16 May 13 | 1:00
-
-
Korean News Second Edition 18 May
18 May 13 | 20:00
-
-
Living Black: S18 Ep11 - Bourke Maternity preview
16 May 13 | 1:00
-
-
Living Black: S18 Ep11 - Bush Blitz preview
16 May 13 | 0:00
-
-
Living Black: S18 Ep11 - KMC Creations preview
16 May 13 | 0:00
-
-
Abbott's budget reply: Full speech
16 May 13 | 28:00
-
-
Stem cell breakthrough causes a stir
16 May 13 | 2:00
-
-
Australia halts transfers to Afghan jail
16 May 13 | 2:00
-
-
GP bills 'may rise' under budget changes
15 May 13 | 1:00
-
-
Federal budget: SBS gets extra funding
15 May 13 | 0:00
-
-
Federal budget: What Australians think
15 May 13 | 2:00
-
-
Mastectomy patient shares life experience
15 May 13 | 7:00
-
-
Budget analysis: Shane Oliver extended interview
15 May 13 | 7:00
-
-
Mixed reaction to federal budget
14 May 13 | 1:00
-
-
Budget 2013: Winners and losers
14 May 13 | 4:00
-
-
What the budget means for the economy
14 May 13 | 2:14
-
-
SBS interview: Hockey slams budget deficit
14 May 13 | 2:00
-
-
Budget analysis: Karen Middleton reports
14 May 13 | 1:00
-
-
Swan discusses budget with SBS
14 May 13 | 2:00
-
-
Budget outcome for Indigenous Australians
14 May 13 | 1:00
-
-
Budget summary: Karen Middleton reports
14 May 13 | 1:00
-
-
Analysis: Impact of funding cuts to universities
14 May 13 | 2:00
-
-
Behind the scenes of the federal budget
14 May 13 | 0:00
Radio News Bulletin
- Latest Bulletin
Fri 17th May 2013 6:45AM - Featured Stories
Wed 30th Nov -0001 12:00AM - Labor's numbers can't be trusted, says Abbott
Fri 17th May 2013 12:00AM - Mainland excision move condemned
Fri 17th May 2013 12:00AM - More calls for asylum seeker work rights
Fri 17th May 2013 12:00AM
Blogs
More Blogs-
-
End of parity: Experts say A$ heading south
17 May 2013, 18:13 PM
-
-
The winning costs of Eurovision 2013
14 May 2013, 17:40 PM
-
-
Benghazi questions just won't go away
14 May 2013, 8:25 AM
- At-a-glance: Same-sex marriage around the world
- Video of US plane crash in Afghanistan believed to be authentic
- Analysis: 'Illegals' and the erosion of empathy
- Xenophon warns of Malaysia election fraud
- Malaysian elections expose serious divides
- Labor to take disability tax rise to poll
- Who is number 23 million joining? A snapshot of Australia
- Family's plea: Aussie facing Saudi terrorism charges
- Is Tony Abbott wrong to talk of 'illegals'?
- Will Malaysians vote for change?
- At-a-glance: Same-sex marriage around the world
- Is Tony Abbott wrong to talk of 'illegals'?
- Comment: Declining sense of grief over Anzac
- Who is number 23 million joining? A snapshot of Australia
- Murrawarri people take sovereignty campaign to UN
- Australia rejects calls to boycott Sri Lanka meet
- Made in Bangladesh 'a label of concern'
- Analysis: 'Illegals' and the erosion of empathy
- Comment: Why are we debating 'blackface' in 2013?
- How young is too young to change sex?
Promote Advertisement
Frank Schleck, the Tour de France and doping: so what's xipamide?
RELATED
By James Heathers, University of Sydney
After the recent re-ignition of allegations against seven-time Tour de France winner Lance Armstrong, many in professional cycling had hoped for a quiet year on the doping front. But, it seems, the Tour de France always delivers.
In 2006, it was Floyd Landis (testosterone). In 2008, it was Bernhard Kohl (EPO receptor activator). In 2010, it was Alberto Contador (clenbuterol). Now, we may have a scalp for this year. Luxembourg’s Frank Schleck, last year’s third-place finisher, has returned an A-sample showing positive for the banned diuretic xipamide.
Diuretics – what’s the point?
You might think a diuretic – a drug that increases urine and sodium excretion – would be a strange choice for performance enhancement in a sport where dehydration is a clear and present danger. And you’d be right.
Diuretics are not at all performance-enhancing by themselves, but have two related functions which places them on the banned-substance list:
1) People who are trying to rapidly lose weight to achieve a lower weight class (think any combat or power sport) will use diuretics to temporarily dehydrate themselves below their weight category limit, “weigh in”, and then rehydrate for competition. An enormous advantage can be gained this way, as athletes frequently compete several kilos above their scale weight.
2) Somewhat more sinisterly, diuretics are used as “masking agents” to hide the presence of other drugs in a urine test. The main method of action for masking is simple. A diuretic increases the amount of urine produced so if an athlete keeps their hydration high and manages their electrolyte balance, they can produce drastically diluted urine which is less likely to show the presence of any other banned performance-enhancing substance.
What is xipamide?
Xipamide is about 40 years old and quite an uncommon diuretic – the World Anti-Doping Authority reported no positive tests for it in 2010, and don’t mention it at all on their website (although it is most assuredly considered a “substance … with a similar chemical structure or similar biological effect” to other diuretics).
Typically, xipamide would be used for the treatment of oedema (fluid retention) or related conditions and has no therapeutic exemption. That is, there is no condition under which you are allowed to test positive to it.
In cases such as Frank Schleck’s, there are several possible explanations apart from laboratory error, which is unlikely:
1) It was taken in the manner described above, as a masking agent.
2) It was ingested as a contaminant (from a food product, medication or athletic supplement). This is increasingly unlikely, given the increasing amount of attention afforded to this problem in professional cycling teams. It also seems that Schleck’s team have categorically ruled this out.
3) To add a layer of intrigue, it’s possible the substance remained as a contaminant from blood doping – that blood was drawn out and contaminated at an earlier time and then recently re-injected.
It may be possible to determine more precisely what is going on from the level of xipamide present, or other related factors.
But as is customary in these cases, the UCI cannot comment any further due to privacy concerns, so all we are left with in the meantime is speculation and another year’s worth of recrimination.
One thing is for certain though: Frank Schleck’s Tour 2012 is over.
Further reading:
Tour de France: the science of hill climbing
Suffer score: how demanding is Le Tour de France?
Le Tour de France is set to roll, so what makes a perfect bike wheel?
High-end bikes for sale … but what are you really buying?
Cadel Evans and other machines: the science of the Tour de France time trial
Science of elite cycling: Tour de France (stage 1 to 11)
Science of elite cycling: Tour de France (stage 12 to 21)
James Heathers does not work for, consult to, own shares in or receive funding from any company or organisation that would benefit from this article, and has no relevant affiliations.
![]()
VideoNEW
Podcasts
Blogs


